Abstract. With the industrialization of society, the increase in the prevalence of obesity and metabolic disorders has become an important health concern in a number of countries. Quercetin (3,30,40,5,7-pentahydroxyflavone) is well known as a bioactive flavonoid in a variety of biological resources. The aim of the present study was to explore the machanisms responsible for the anti-adipogenic activity of quercetin and its effects on the lipolysis in OP9 mouse stromal cells which rapidly differentiate into adipocytes. The differentiation of OP9 cells into adipocytes was evaluated by the measurement of lipid accumulation by Oil Red O (ORO) staining; lipid accumulation was significantly impaired by treatment with quercetin. Reverse transcriptionpolymerase chain reaction (RT-PCR) and western blot analysis were used to measure the expression levels of CCAAT/enhancer binding protein α (C/EBPα), proliferator-activated receptor γ (PPARγ), sterol regulatory element-binding protein-1 (SREBP-1) and fatty acid synthase (FAS). The mRNA expression levels of lipases, such as adipose triglyceride lipase (ATGL), hormone sensitive lipase (HSL) and lipoprotein lipase (LPL) were also measured by RT-PCR. Quercetin significantly decreased the expression of transcription factors, including C/EBPα, PPARγ and SREBP-1c both at the protein and mRNA level. The results from the present study demonstrate that quercetin prevents adipogenesis by upregulating ATGL and HSL expression and downregulating FAS, LPL and adipocyte fatty acid-binding protein (aP2) expression, as well as the expression of transcription factors. Our data suggest that quercetin has therapeutic potential by regulating the expression of transcriptional factors and enzymes associated with adipogenesis.
Introduction
The increasing prevalence of obesity is a major health concern in industrialized countries. Obesity is a primary causative factor in the development of metabolic disorders, such as hypertention, insulin resistence and type II diabetes, which is a complex, multi-factorial and chronic disease (1) . Obesity is characterized by the accumulation of inordinate fat in the body which involves the pathological growth of adipocytes caused by an imbalance in energy intake and expenditure (2) .
The maintenance of lipid homeostasis and energy balance is connected to adipocytes that regulate the storage of triglycerides (TGs) or the release of free fatty acids (FFAs) through changes in energy states (3, 4) . Adipocytes not only control lipid metabolism, but also glucose metabolism and endocrine function through insulin-dependent glucose uptake and the secretion of hormones and cytokines (5) . Adipogenesis is the process through which an undifferentiated preadipocyte is reorganized into a fully differentiated adipocyte (6) . The differentiation process through which preadipocytes are converted into adipocytes is associated with the stimulation of transcriptional factors, including CCAAT/enhancer-binding protein α (C/EBPα) and peroxisome proliferator activated receptor γ (PPARγ). When the cascade of transcription factors is initiated, the induction of differentiation begins and the expression of C/EBPα and PPARγ increases from undetectable levels in preadipocytes to detectable levels within 2 days; C/EBPα and PPARγ are fully expressed following the initiation of the differentiation process within approximately 5 days (7) . This activation of transcription factors leads to terminal differentiation and regulates the expression of genes involved in the induction of the adipocyte phenotype (7) .
Adipogenesis is characterized by the accumulation of TGs accompanied by an increase in the expression of various enzymes that are involved in lipogenesis or lipolysis. Sterol regulatory element binding proteins (SREBPs) are transcription factors that control both cholesterol and fatty acid biosynthetic processes, termed lipogenesis. SREBP-1c which is one of the SREBP isoforms, has been shown to play a role in fatty acid synthesis and insulin-induced glucose metabolism (8) . Fatty acid synthase (FAS), which is key enzyme of lipogenesis that produces long-chain fatty acids from acetyl-coA and (12) . ATGL decomposes TGs into diglycerides (DGs) that are hydrolyzed by HSL (13, 14) . Quercetin (3,30,40,5,7-pentahydroxyflavone) is one of the most common and bioactive flavonoids found in a variety of vegetables, fruits and botanicals, such as red onions, apples and tea (15) . It has attracted much attention as a potential antioxidant of dietary origin. Previous studies have indicated that quercetin has multiple pharmacological effects, such as the scavenging of oxygen radicals, the prevention of lipid peroxidation, as well as anti-adipogenic, anti-apoptotic and anti-inflammatory effects (16) (17) (18) (19) . However, to the best of our knowledge, there is no published study to date on adipogenesis and lipolysis in OP9 cells. The association between quercetin and lipolyis remains undetermined. Thus, the aim of this study was to determine the effects of quercetin on adipogenesis and lipolysis. Furthermore, we investigated the molecular mechanisms of action of quercetin in OP9 mouse stromal cells, a new model of adipocytes.
Quercetin prevents adipogenesis by regulation of transcriptional factors and lipases in OP9 cells

Materials and methods
Materials. Quercetin used in this study was purchased from Sigma-Aldrich (St. Louis, mΟ, uSA). The Oil Red O (ORO) staining dye was also purchased from Sigma-Aldrich. Cell culture. OP9 cells, bone marrow-derived mouse stromal cells, were obtained from the American Type Culture Collection (ATCC, manassas, vA, uSA) and grown in α-minimum essential medium (α-mEm) supplemented with 20% fetal bovine serum (FBS), 100 u/ml penicillin, 100 µg/ml streptomycin and 2 mm L-glutamine (HyClone ® , Thermo Scientific, Logan, uT, uSA). The cells were cultured at 37˚C in a humidified atmosphere of 95% air to 5% CO 2 .
Cell differentiation into adipocytes. Adipocyte differentiation was induced as previously described (20) with minor modifications. OP9 preadipocytes were seeded at 60,000 cells/cm 2 . The cells allowed to reach confluence for 2 days. At this time point (day 0), the medium were switched to mDI differentiation medium [α-mEm, 10% FBS, 0.25 µm dexamethasone, 0.25 mm isobutylmethylxanthine (IBmX) and 10 µg/ml insulin] for 2 days. At this time point, the cells were treated with differentiation medium in the presence of various concentrations of quercetin to examine the effects of quercetin on adipogenesis. On day 2, the dexamethasone and IBmX were removed, leaving insulin in the cell medium with or without quercetin for an additional 2 days. Thereafter, the cells were maintained in the original propagation α-mEm with changes in medium every 2 days. On day 6, when the differentiation process was completed, the cells were harvested.
Cytotoxicity assay. Cell viability was examined by mTS assay. Briefly, the OP9 cells were seeded at a density of 1x10 6 cells/ ml in 96-well plates. In order to determine the concentration of quercetin which is non-toxic to the cells, quercetin (5, 10, 25, 50 and 100 µm) was then added to each well. The plates were then incubated for 24 h at 37˚C under 5% CO 2 . mTS solution (5 mg/ml) was added to each well and the cells were then cultured for a further 2 h, after which the optical density was read at 490 nm. Cytotoxicity was then calculated using the following formula: 1 -(mean absorbance value of treated cells/ mean absorbance value of untreated cells).
ORO staining. For the examination of fat accumulation in the OP9 cells, the cells were treated as described above in 'Cell differentiation into adipocytes'. The cells were rinsed with cold phosphate-buffered saline (PBS) twice and fixed in 10% paraformaldehyde for 30 min in room temperature. After the cells were washed with 60% isopropanol, the cells were stained for at least 1 h in a freshly diluted 0.3% ORO solution (6 parts 0.5% ORO stock solution in isopropanol and 4 parts H 2 O). After the stain was removed and the cells were washed with 60% isopropanol, an image of each group was acquired using an Olympus IX71 Research Inverted Phase microscope (Olympus Co., Tokyo, Japan). The stained lipid droplets were then extracted with isopropanol for quantification by measuring its absorbance at 490 nm.
Reverse transcriptase-polymerase chain reaction (RT-PCR).
Total RNA was isolated using an easy-BLuE total RNA extraction kit (iNtRon, Seongnam, korea) according to the instructions provided by the manufacturer. Single-strand cDNA synthesis was performed using the QuantiTect reverse transcription kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. PCR reactions were performed in a total volume of 20 µl comprising 2 µl of cDNA product, 0.2 mM of each dNTP, 20 pmol of each primer and 0.8 units of Taq polymerase. The primer sequences for C/EBPα, PPARγ, SREBP1, FAS, adipocyte fatty acid-binding protein (aP2), ATGL, HSL, LPL and β-actin are presented in Table I . PCR reactions were conducted under the following conditions: 95˚C for 3 min (1 cycle), 95˚C for 30 sec, 50-62˚C for 30 sec, 72˚C for (40 cycles). The PCR products increased as the concentration of the RNA increased. Finally, the products were electrophoresed on a 2.0% agarose gel using the Dyne Gel Safe Red kit (II) (DyneBio, Seongnam, korea) visualized under uv light.
Western blot analysis. Protein expression was assessed by western blot analysis according to standard procedures. The OP9 cells which had completed the differentiation process were washed twice in PBS. The cell pellets were resuspended in lysis buffer on ice for 20 min, and the supernatant was collected by centrifugation (13,000 rpm, 10 min, 4˚C). The protein concentrations in the supernatant were determined using the Bio-Rad protein assay reagent (Bio-Rad Laboratories, Hercules, CA, uSA) according to the manufacturer's instructions. Equal amounts of protein (20 µg) were subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto a polyvinylidene membrane (Millipore, Bedford, mA, uSA). The membrane was blocked for >1 h with 5% skim milk in Tris-buffered saline (150 mm NaCl and 20 mm Tris-HCl, pH 7.4) with 0.05% Tween-20. After blocking, the membrane was incubated with primary antibodies for 18 h. The membrane was then washed with Tris-buffered saline with Tween-20 and incubated with anti-mouse or antirabbit immunoglobulin G horseradish peroxidase-conjugated secondary antibodies. The proteins were then supplemented with ECL prime western blot detection reagents and the ImageQuant LAS 4000 mini Biomolecular Imager (both from GE Healthcare, Buckinghamshire, uk) was used for evaluating the bands. The bands were quantified using ImageJ software.
Statistical analysis. Statistical analysis was performed followed by one-way analysis of variance (ANOvA) using IBm SPSS statistical software version 19. The data from the experiments are presented as the means ± SD.
Results
Cytotoxicity of quercetin in OP9 cells.
To evaluate the effects of quercetin on the viability of OP9 cells, the cells were treated with various concentrations of quercetin (0, 5, 10, 50 and 100 µm) and mTS assay was then conducted. Our data indicated that quercetin was not cytotoxic to the OP9 cells (Fig. 1) . Quercetin at the concentration of 5, 10 and 50 µm was used to evaluate its anti-adipogenic activity.
Inhibitory effects of quercetin on the differentiation of OP9 cells into adipocytes.
The OP9 cells were treated with quercetin (5, 10 and 50 µm) to determine its effects on the accumulation of lipid droplets in the cytoplasm. After the preadipocytes had differentiated into adipocytes, morphological alterations were observed due to the accumulation of intracellular lipids ( Fig. 2A) . As shown by our results, lipid accumulation in the quercetin-treated cells was significantly decreased compared with the untreated cells. The quantitative data of ORO staining indicated that treatment with quercetin at 10 and 50 µm led to a 11.5 and 34.4% decrease in lipid accumulation, respectively (Fig. 2B) .
Effect of quercetin on the expression of transcriptional regulators.
To determine the effects of quercetin on adipocyte differentiation at the protein level, western blot analysis was performed to measure the expression of factors and enzymes associated with adipogenis. The adipocytes undergoing mDI-induced differentiation were treated with various doses of quercetin (0, 5, 10 and 50 µm). The increase in C/EBPα, PPARγ and SREBP-1 protein expression was significantly suppressed by treatment with quercetin (Fig. 3A) . The expression levels of C/EBPα and PPARγ were decreased following treatment with quercetin in a dose-dependent manner. The mRNA expression levels were also significantly decreased in the cells treated with quercetin following adipocyte differentiation compared with the untreated cells (Fig. 3B ). Following treatment with 5, 10 and 50 µm quercetin, the expression of SREBP-1 was reduced to 57.2, 42.7 and 33%, respectively in a dose-dependent manner compared with the untreated cells. Following treatment with 50 µm quercetin, the expression level of C/EBPα and PPARγ also decreased to 71.6 and 71.7%, respectively (Fig. 3D) . 
Downregulatory effects of quercetin on FAS and aP2 expression.
Quercetin significantly decreased the mRNA expression levels of FAS and aP2 in the OP9 adipocytes (Fig. 4) . Our results revealed that treatment with quercetin (50 µm) significantly decreased FAS and aP2 mRNA expression by 48.3 and 37.1%, respectively when compared with the untreated cells (Fig. 4B) .
Additionally, a decrease in FAS mRNA expression was observed following treatment with various concentrations of quercetin in a dose-dependent manner.
Effect quercetin on the mRNA expression of ATGL, HSL and LPL in OP9 adipocytes.
To determine the effects of quercetin on lipases, RT-PCR was performed. The results revealed that there was a significant increase in the expression of ATGL and HSL (Fig. 5A) following treatment with quercetin. The mRNA expression levels of of ATGL increased by >4-fold in a dose-dependent manner compared with the untreated cells. In addition, the expression of HSL increased by >2-fold compared with the untreated cells (Fig. 5B) . It can be observed from the results presented in Fig. 5 that LPL expression was deceased in the OP9 adipocytes treated with quercetin.
Discussion
The present study demonstrated that quercetin inhibited the differentiation of OP9 preadipocytes induced by hormone cocktail treatment. In fact, treatment with quercetin decreased adipogenesis in the differentiated OP9 cells, as indicated by measurements of total lipid accumulation; quercetin also downregulated the expression of key adipogenesis-related transcription factors and their target genes. moreover, we demonstrated that the treatment of adipocytes with quercetin enhanced lipolytic activity by increasing the expression levels of lipases, thereby diminishing lipid storage in adipocytes.
OP9 mouse stromal cells have received attention as a new useful model of rapid adipogenesis for the study of adipocyte biology (20) . Adipocyte differentiation in response to various stimuli is a complex process involving coordinated changes in hormone sensitivity and gene expression. Adipogenesis is characterized by the accumulation of intracellular lipid droplets fully filled with TGs that are synthesized followed by lipogenesis with glycerol and fatty acids. Our findings indicated that treatment with quercetin markedly decreased the accumulation of intracellular TGs (Fig. 2) . The number of lipid droplets in the adipocytes was significantly decreased and the amount of lipids in the cytoplasm also decreased following treatment with quercetin.
Adipogenesis requires the sequential activation of numerous transcription factors, including PPARγ, C/EBPs and SREBPs (7, (21) (22) (23) . The expression C/EBPα and PPARγ genes is sequentially activated by early-phase transcription factors, such as C/EBPβ and C/EBPδ, key transcription factors in the adipogenesis (24) . The expression of C/EBPα and PPARγ increases the expression of downstream target genes that are involved in TG metabolism and finally leads to fully differentiated adipocytes (25) . As shown by our data, the mRNA and protein expression levels of C/EBPα and PPARγ (Fig. 3) were significantly decreased by treatment with quercetin compared with the untreated cells. It has also been previously demonstrated that SREBP-1c plays an important role in the regulation of the mRNA expression of genes involved in adipocyte differentiation and fatty acid synthesis (26) . In this study, the expression of SREBP-1c was decreased in the adipocytes treated with quercetin compared with the untreated cells. The fact that C/EBPα and PPARγ are essential for the intitiation of the cascade of transcription factors that lead to adipogenesis and that SREBP-1c is associated with lipogenesis and transcription, suggests that quercetin has ability to prevent adipogenesis, as shown by our results.
Adipogenesis can be induced through changes in the expression of programmed specific genes, such as FAS and aP2. These genes are regulated by transcription factors, such as PPARγ, C/EBPα and SREBP-1c, which are known to be critical activators of adipogenesis (5). The aP2 and FAS genes are known as terminal differentiation markers of adipocytes. The aP2 gene plays a central role in the pathway which links obesity to insulin resistance and fatty acid metabolism. The expression of the FAS enzyme is involved in lipoginesis and leads to the activation of PPARγ and SREBP-1c as a metabolic cascade. This activation is also clearly able to cross-activate the FAS promoter (27) . In the present study, treatment with quercetin induced the downregulation of the FAS gene, as well as the aP2 gene (Fig. 4) . Thus, quercetin may suppress the downstream adipocyte-specific gene promoters, including aP2 and FAS, which are associated with adipocyte differentiation and lipogenesis.
Since quercetin suppressed intracellular lipid accumulation, we examined the effects of quercetion not only on transcription factors involved in adipocyte differentiation, but also on lipases, such as ATGL, HSL and LPL associated with lipolysis. Previous studies have demonstrated that ATGL is capable of hydrolyzing TGs and that the level of ATGL determines the rate of lipolysis (14) . ATGL selectively performs the first step in TG hydrolysis resulting in the formation of DGs and FFAs (12) . HSL has been shown to exhibit broad substrate specificity and is capable of hydrolyzing cholesterylester, TGs, DGs and monoacylglycerol. The enzyme is most active against DGs which are hydrolyzed ~10-fold nore rapidly than TGs (28) . In this study, quercetin significantly increased the adipocyte mRNA levels of the major TG lipases, ATGL and HSL. Treatment with quercetin stimulated lipolysis, indicated by the increased expression of ATGL and HSL, leading to TG hydrolysis. LPL is a main lipoprotein enzyme in fat cells and is secreted into capillary vessels and cell envelopes and participates in lipoprotein metabolism (29) . LPL is an early marker of adipocyte differentiation that dissolves lipids in lipoproteins, such as very low density lipoprotein (vLDL) and low density lipoprotein (LDL) into one monoacylglycerol and two FFAs to allow fatty acid entry into fat tissue; thus, the overexpression of LPL indicates the initiation of lipid accumulation (30) .
In our study, the mRNA expression level of LPL in adipocytes treated with quercetin was markedly decreased by up to 48.4%. This result indicated that quercetin suppressed the accumulation of intracellular TGs by downregulating LPL and upregulating ATGL and HSL (Fig. 5) .
In the present study, we examined the effects of quercetin on the differentiation of preadipocytes into adipocytes and the mechanisms responsible for the prevention of adipogenesis. Our data indicated quercetin suppressed the expression of transcription factors, such as PPARγ, C/EBPα and SREBP-1c and their downstream target genes, including FAS and aP2. In addition, quercetin regulated the expression of enzymes associate with lipolysis, such as ATGL, HSL and LPL. These results suggest that quercetin has potential for use in the prevention of adipogenesis. However, further studies are required to explore the full potential of quercetin in the management of obesity.
